Orapharma, Inc. is a biotechnology company based in Bridgewater, NJ, specializing in the development and commercialization of innovative therapies for oral health. The organization focuses on addressing unmet medical needs through advanced research in areas such as periodontal disease and oral infections. By leveraging cutting-edge technology and scientific expertise, Orapharma aims to enhance patient outcomes and improve the quality of life for individuals suffering from oral health conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

12 Patents

#23 in Bridgewater, NJ

#961 in New Jersey

#25,578 in US

#48,209 in the World

Bridgewater, NJ, United States of America

Orapharma, Inc.

Forward Citations = 120

12 inventors:

James Ronald Lawter (11 out of 11 patents)

Zhangwen Wu (6 out of 8 patents)

Michael Joseph Rello (6 out of 13 patents)

4. Stephen Comiskey (3 out of 23 patents)

5. Charles D Faust (3 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Orapharma, Inc.. Retrieved from https://idiyas.com/company/orapharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]